XWELL (NASDAQ:XWEL) Shares Up 0.6% – Should You Buy?

XWELL, Inc. (NASDAQ:XWELGet Free Report) traded up 0.6% during trading on Friday . The stock traded as high as $0.9756 and last traded at $0.9756. 16,438 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 39,345 shares. The stock had previously closed at $0.97.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on XWEL. Wall Street Zen lowered shares of XWELL from a “hold” rating to a “sell” rating in a research note on Sunday, May 17th. Weiss Ratings upgraded XWELL from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 24th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.

View Our Latest Stock Analysis on XWEL

XWELL Price Performance

The stock has a fifty day moving average price of $1.01 and a two-hundred day moving average price of $1.15. The company has a market cap of $8.23 million, a P/E ratio of -0.18 and a beta of 1.00.

XWELL (NASDAQ:XWELGet Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.00) by $0.74. XWELL had a negative return on equity of 1,091.48% and a negative net margin of 82.90%.The business had revenue of $7.14 million during the quarter, compared to analyst estimates of $2.37 million.

XWELL Company Profile

(Get Free Report)

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.

See Also

Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.